Kamada (KMDA) Consolidated Net Income (2012 - 2026)
Kamada (KMDA) reported Consolidated Net Income of $4.1 million for Q1 2026, down 55.39% on a YoY basis from $9.3 million in Q1 2025, and down 30.04% quarter-over-quarter from $5.9 million in Q4 2025.
Kamada (KMDA) Consolidated Net Income (2012 - 2026) Analysis & Trends
Kamada has reported Consolidated Net Income for 15 years, with the latest figure at $4.1 million in Q1 2026.
- For the quarter ending Q1 2026, Consolidated Net Income fell 55.39% year-over-year to $4.1 million; the trailing twelve-month figure through Mar 2026 stood at $18.5 million (up 8.48% YoY), and the FY2025 full-year result was $26.7 million, up 119.04% from the prior year.
- Consolidated Net Income for Q1 2026 stood at $4.1 million, down from $5.9 million in the prior quarter.
- The five-year high for Consolidated Net Income was $9.3 million in Q1 2025, with the low at -$3.9 million in Q2 2022.
- Historically, Consolidated Net Income has averaged $2.7 million across 5 years, with a median of $2.9 million in 2022.
- Annual changes were most pronounced in 2022 — Consolidated Net Income slumped 518.46% — and 2024, when it surged 139016.53%.
- Kamada's Consolidated Net Income stood at $2.9 million in 2022, then jumped by 71.81% to $5.1 million in 2023, then dropped by 24.71% to $3.8 million in 2024, then jumped by 55.09% to $5.9 million in 2025, then tumbled by 30.04% to $4.1 million in 2026.
- The last three Consolidated Net Income figures came in at $4.1 million (Q1 2026), $5.9 million (Q4 2025), and $8.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Consol Net Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 370.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 601.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 274.90 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -114,733.81 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 197.90 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 57.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -66.53 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 118.42 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -92.12 Mn |
| 10 | Kamada | 505.05 | -73.15 Mn | 19.12 Mn | 4.13 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.13 Mn |
| Dec 31, 2025 | 5.91 Mn |
| Sep 30, 2025 | 8.45 Mn |
| Jun 30, 2025 | 4,130.00 |
| Mar 31, 2025 | 9.26 Mn |
| Dec 31, 2024 | 3.81 Mn |
| Sep 30, 2024 | 4.03 Mn |
| Jun 30, 2024 | -58,511.00 |
| Mar 31, 2024 | 2.51 Mn |
| Dec 31, 2023 | 5.06 Mn |
| Sep 30, 2023 | 3.22 Mn |
| Jun 30, 2023 | 1.84 Mn |
| Mar 31, 2023 | -1,809.00 |
| Dec 31, 2022 | 2.94 Mn |
| Sep 30, 2022 | 493,990.00 |
| Jun 30, 2022 | -3.92 Mn |
| Mar 31, 2022 | -1.83 Mn |
| Dec 31, 2021 | -4.66 Mn |
| Sep 30, 2021 | -845,000.00 |
| Jun 30, 2021 | 937,000.00 |